690 related articles for article (PubMed ID: 25733340)
21. Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
Taxonera C; Barreiro-de Acosta M; Calvo M; Saro C; Bastida G; Martín-Arranz MD; Gisbert JP; García-Sánchez V; Marín-Jiménez I; Bermejo F; Chaparro M; Ponferrada Á; Martínez-Montiel MP; Pajares R; de Gracia C; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I
Dig Dis Sci; 2015 Oct; 60(10):3075-84. PubMed ID: 26044830
[TBL] [Abstract][Full Text] [Related]
22. Infliximab efficacy in pediatric ulcerative colitis.
Eidelwein AP; Cuffari C; Abadom V; Oliva-Hemker M
Inflamm Bowel Dis; 2005 Mar; 11(3):213-8. PubMed ID: 15735427
[TBL] [Abstract][Full Text] [Related]
23. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
Mocciaro F; Orlando A; Scimeca D; Cottone M
Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
[TBL] [Abstract][Full Text] [Related]
24. Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.
Sebastian S; Myers S; Argyriou K; Martin G; Los L; Fiske J; Ranjan R; Cooper B; Goodoory V; Ching HL; Jayasooriya N; Brooks J; Dhar A; Shenoy AH; Limdi JK; Butterworth J; Allen PB; Samuel S; Moran GW; Shenderey R; Parkes G; Lobo A; Kennedy NA; Subramanian S; Raine T
Aliment Pharmacol Ther; 2019 Sep; 50(6):675-683. PubMed ID: 31456297
[TBL] [Abstract][Full Text] [Related]
25. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
[TBL] [Abstract][Full Text] [Related]
26. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
27. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.
Thorne K; Alrubaiy L; Akbari A; Samuel DG; Morrison-Rees S; Roberts SE
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):369-82. PubMed ID: 26825217
[TBL] [Abstract][Full Text] [Related]
28. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C
Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208
[TBL] [Abstract][Full Text] [Related]
29. Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed?
Clemente V; Aratari A; Papi C; Vernia P
Dig Liver Dis; 2016 Apr; 48(4):371-5. PubMed ID: 26854257
[TBL] [Abstract][Full Text] [Related]
30. Surgical and medical treatment in patients with acute severe ulcerative colitis.
Fornaro R; Caratto M; Barbruni G; Fornaro F; Salerno A; Giovinazzo D; Sticchi C; Caratto E
J Dig Dis; 2015 Oct; 16(10):558-67. PubMed ID: 26315728
[TBL] [Abstract][Full Text] [Related]
31. A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks.
Baudet A; Colombel JF; Cortot A; Dupas JL; Brazier F; Savoye G; Lerebours E; Justum AM; Reimund JM
Gastroenterol Clin Biol; 2010 Nov; 34(11):612-7. PubMed ID: 20832218
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes of infliximab treatment and predictors of response in 195 patients with ulcerative colitis: a hospital-based cohort study from Korea.
Seo H; Chang K; Lee SH; Song EM; Kim GU; Seo M; Lee HS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH
Scand J Gastroenterol; 2017 Aug; 52(8):857-863. PubMed ID: 28502189
[TBL] [Abstract][Full Text] [Related]
33. Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals.
Mortensen C; Caspersen S; Christensen NL; Svenningsen L; Thorsgaard N; Christensen LA; Bendtsen F
J Crohns Colitis; 2011 Feb; 5(1):28-33. PubMed ID: 21272801
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.
Rolny P; Vatn M
Scand J Gastroenterol; 2013 Feb; 48(2):131-5. PubMed ID: 23110487
[TBL] [Abstract][Full Text] [Related]
35. Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study.
Kim EH; Kim DH; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Gut Liver; 2015 Sep; 9(5):601-6. PubMed ID: 25473080
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.
Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thörn M; Björk J; Hindorf U; Löfberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E;
Aliment Pharmacol Ther; 2017 Feb; 45(4):519-532. PubMed ID: 28025840
[TBL] [Abstract][Full Text] [Related]
38. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
[TBL] [Abstract][Full Text] [Related]
39. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
40. Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
Syal G; Robbins L; Kashani A; Bonthala N; Feldman E; Fleshner P; Vasiliauskas E; McGovern D; Ha C; Targan S; Melmed GY
Dig Dis Sci; 2021 Jan; 66(1):199-205. PubMed ID: 32170473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
